Purpose: To compare readout-segmented echo-planar imaging (EPI) (RESOLVE) to single-shot EPI (ss-EPI) diffusionweighted imaging (DWI) for the assessment of renal interstitial fibrosis. Materials and Methods: A phantom, eight healthy volunteers (under 30 years to avoid age-fibrosis related) and 27 chronic kidney disease (CKD) patients (scheduled for kidney biopsy) were scanned (at 3T) with ss-EPI and 5-shot RESOLVE DWI (resolution: 2 3 2 3 5 mm 3 , 10 b-values). The cortico-medullary difference for each DW parameter from a monoexponential fit (DADC) or, segmented biexponential fit (DD, DD*, DF p ) were compared between both sequences. A fibrosis threshold of 40% was defined to separate all 35 subjects into low and high fibrosis groups. The linear relationship between DW parameters and percentage fibrosis (up to 80%) from Masson trichrome was assessed with the Pearson product-moment correlation coefficient. Fisher Z-transform was used for R 2 correlation comparison. Results: A coefficient of variation between ADCs of 3% was measured between both sequences in the phantom. In healthy volunteers, no significant difference was measured for all DW parameters. Both sequences separated low to high level of fibrosis with a significant decrease of DADC (RESOLVE P 5 3.1 3 10 -6
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Purpose: To compare readout-segmented echo-planar imaging (EPI) (RESOLVE) to single-shot EPI (ss-EPI) diffusionweighted imaging (DWI) for the assessment of renal interstitial fibrosis. Materials and Methods: A phantom, eight healthy volunteers (under 30 years to avoid age-fibrosis related) and 27 chronic kidney disease (CKD) patients (scheduled for kidney biopsy) were scanned (at 3T) with ss-EPI and 5-shot RESOLVE DWI (resolution: 2 3 2 3 5 mm 3 , 10 b-values). The cortico-medullary difference for each DW parameter from a monoexponential fit (DADC) or, segmented biexponential fit (DD, DD*, DF p ) were compared between both sequences. A fibrosis threshold of 40% was defined to separate all 35 subjects into low and high fibrosis groups. The linear relationship between DW parameters and percentage fibrosis (up to 80%) from Masson trichrome was assessed with the Pearson product-moment correlation coefficient. Fisher Z-transform was used for R 2 correlation comparison. Results: A coefficient of variation between ADCs of 3% was measured between both sequences in the phantom. In healthy volunteers, no significant difference was measured for all DW parameters. Both sequences separated low to high level of fibrosis with a significant decrease of DADC (RESOLVE P 5 3.1 3 10 -6 , ss-EPI P 5 0.003) and DD (RESOLVE P 5 8.2 3 10 -5 , ss-EPI P 5 0.02) in the high level of fibrosis. However, RESOLVE DADC had a stronger negative correlation (P 5 0.04 for R 2 comparison) with fibrosis than ss-EPI DADC (RESOLVE R 2 5 0.65, P 5 5.9 3 10 -9 , ss-EPI R 2 5 0.29, P 5 8.9 3 10 -4 ). DD (RESOLVE) was correlated (moderately) with fibrosis (R 2 5 0.29, P 5 9.2 3 10 -4 ); however, DD* and DF p did not show, in our population, a significant correlation with interstitial fibrosis (0.01 < R 2 < 0.08). Conclusion: DADC derived from both sequences correlated with fibrosis. DADC from RESOLVE showed better correlation with fibrosis than DADC from ss-EPI and therefore has potential to monitor CKD. C hronic kidney disease (CKD) is defined as an alteration of kidney structure and/or function lasting for more than 3 months. 1 The prevalence of CKD is high, with about 1 in 10 adults suffering from some degree of CKD. 2 The level of kidney cortical interstitial fibrosis (from now on referred to as interstitial fibrosis) is recognized as an indicator of impaired renal function and is also predictive of a more serious evolution in most kidney diseases. 3 Renal interstitial fibrosis is characterized by changes in the interstitial space, such as a deposition of extracellular collagen and the destruction of renal tubules and interstitial capillaries. 4 Currently, the gold standard to evaluate these structural alterations is kidney biopsy. However, this procedure is difficult to perform repeatedly and is associated with a risk of hemorrhage as well as sampling bias. There is currently no validated noninvasive method to diagnose and monitor renal interstitial fibrosis.
Magnetic resonance imaging (MRI) with diffusionweighted imaging (DWI) is emerging as a tool to assess renal interstitial fibrosis. DWI enables assessment of water molecule mobility via quantification of parameters such as the apparent diffusion coefficient (ADC), the most widely used, from a monoexponential fit, as well as pure diffusion (D), perfusioninduced pseudodiffusion (D*), and perfusion fraction (F p ) coefficients from a biexponential fit. ADC from DWI correlates with interstitial fibrosis in CKD patients and animal models [6] [7] [8] and carries potential to change the diagnostic workup and follow-up of CKD patients. However, ADC measurements are technically challenging and highly variable. Generally, renal DWI is performed using a single-shot k-space trajectory, namely, single-shot echo-planar imaging (ss-EPI), which suffers from artifacts due to a long echo train length (ETL). 9 Off-resonance and T Ã 2 blurring artifacts associated with the long ETL can be reduced by increasing the receiver bandwidth and by the use of parallel imaging techniques such as generalized autocalibrating partially parallel acquisitions (GRAPPA) to reduce the echo spacing. However, this combination, although improving the DW image quality, is not sufficient for renal applications when higher resolution is required as, for example, to differentiate cortex and medulla. 10 The readout segmentation of long variable echo train (RESOLVE) strategy has been proposed to improve the quality of DWI. With this technique, Porter and Heidemann showed a reduction of the signal blurring due to the T Ã 2 decay during the echo-train in the phase-encoding direction. 11 In this encoding scheme, k-space is divided into several shots along the readout direction in order to shorten the echo train length, leading to a longer acquisition time (approximately multiplied by the number of shots) compared to traditional ss-EPI DWI. Recently, improvements in renal interstitial fibrosis assessment was obtained by the use of the RESOLVE sequence associated with the cortico-medullary ADC difference (DADC) parameter. 12 DADC derived from the RESOLVE sequence was used as a marker to detect a level of more than 40% interstitial fibrosis. In a homogenous population of kidney allograft patients undergoing biopsy, those with more than 40% interstitial fibrosis harbored a negative DADC, while a positive DADC was measured in patients with less than 40% interstitial fibrosis. Therefore, RESOLVE-derived DADC has a strong potential for clinical applications. However, the RESOLVE sequence is significantly longer than ss-EPI, which could be particularly disadvantageous in the abdomen, where respiratory triggering is mandatory. It is not known if the observed good correlation between DADC and interstitial fibrosis 12 would still be valid with an MR sequence of shorter acquisition time, ie, ss-EPI. Therefore, the aim of the present study was to compare RESOLVE and ss-EPI DW sequences for the assessment of renal interstitial fibrosis.
Materials and Methods

Phantom
A home-made DWI phantom inspired by Lavdas et al 13 was built to assess ADC quantification of ss-EPI and RESOLVE in a stable and reproducible manner. A plastic container of 14 3 10 3 9 cm 3 containing three plastic tubes was filled with nickel-doped agarose/ sucrose gel. One tube was surrounded by a safflower oil-filled gap, and the second tube by an air-filled gap. The gel in the plastic container and tubes had two distinct ADC values (referred to as "1" and "2" as shown in Fig. 1 ).
Subjects
This study was performed according to the Declaration of Helsinki and the local Institutional Ethical Committee. Written informed consent for the MRI procedures was obtained from each subject. Eight healthy volunteers (three females and five males, with a mean age of 26 6 2 years [23-29 years]), without known kidney disease or urinary system disease, and with an upper age limit of 30 years to avoid age-fibrosis related, were recruited. A cohort of 27 CKD patients (2 native kidney, 25 kidney allografts) planned for a clinically driven kidney biopsy (9 females and 18 males, with a mean age of 53 6 10 years [31-83 years]) was scanned with the same protocol as healthy volunteers. All CKD patients underwent, on the same afternoon, a research MRI examination, including a RESOLVE and ss-EPI DW sequences, in addition to the renal biopsy. Those acquiring and analyzing the MRI examinations were blinded for medical history and renal pathology assessment. As a subset analysis, the ADC from RESOLVE and the percentage of fibrosis from the first 25 kidney allograft recipients has already been published. 12 Interstitial fibrosis was quantified histologically by a clinical pathologist (25 years of experience) and graded as a percentage from Masson trichrome staining. The percentage of cortical interstitial fibrosis derived from this examination of the kidney biopsy was considered the reference standard.
MRI
MRI was carried out on a 3T clinical Siemens Magnetom Trio (Tim system) scanner (Siemens, Erlangen, Germany) with a combination of the six elements phased-array abdominal coil and the integrated spine coil. The same protocol and coils were used for both phantom and subjects. For morphological images, 10 pseudocoronal slices with the same spatial resolution and orientation as for DWI were acquired with both a T 2 -weighted Half Fourier acquisition single shot turbo spin echo (HASTE) and modified Look-Locker inversion recovery (MOLLI) T 1 mapping sequence.
14 For the functional DWI assessment, the protocol included a navigator-triggered echo planar imaging (EPI) based single-shot readout MR scan (ss-EPI) using PACE (prospective acquisition correction technique) and a RESOLVE 10,11 diffusion-weighted SE-EPI (spin echo based EPI) acquisition synchronized to the patient respiration, using a respiratory belt wrapped around the abdomen. For both ss-EPI and RESOLVE, the sequence parameters were TE/TR 5 68/2200 msec, spatial resolution 5 2 3 2 3 5 mm 3 , parallel imaging (generalized autocalibrating partially parallel acquisitions, GRAPPA) factor 5 3, a bipolar diffusion scheme with the diffusion-encoding gradients applied in three orthogonal directions and 10 b-values (0, 10, 20, 40, 60, 150, 300, 500, 700, and 900 s/mm 2 ). Shim settings and spatial resolution were strictly identical for all MR sequences. The five shot RESOLVE acquisition reduced echo spacing to 0.32 msec from 0.69 msec (ss-EPI) and increased acquisition time to 9 0 47 00 6 4 0 as compared to the ss-EPI at 2 0 20 00 6 1 0 17 00 depending on respiration.
Image Analysis and Data Fitting
MR analysis was performed blinded to histologic results. Freehand regions of interests (ROIs) were manually placed for quantification of both the cortex and medulla as previously described. 12 In brief, two to three cortical ROIs followed the outer contour of the kidney and three medullary ROIs were traced on the T 1 maps and copied on b 0 images, avoiding artifacts, lesions, and major vessels.
Signal intensity values inside ROIs were exported as .csv files with the OsiriX "export ROI" tool plugin and analyzed with MatLab (R2012b, MathWorks, Natick, MA) for diffusion data fitting using a Levenberg-Marquardt algorithm. The apparent diffusion coefficient (ADC) was calculated using a nonlinear least square method for the monoexponential fitting according to the following formula:
where S i is the signal intensity measured on the i th b-value image and S 0 is the signal amplitude in the absence of diffusion weighting (b 5 0 s/mm 2 ). To separate the molecular diffusion from the microcirculation of blood in the capillary network (perfusion), the biexponential model 15 was performed using the segmented fitting method 16 with the following formula:
where D is the diffusion coefficient representing "pure" molecular diffusion (slow component), D* is the perfusion-induced pseudodiffusion coefficient (fast component), and F p is the perfusion fraction, ie, the fraction of the signal intensity S 0 attributed to capillary blood flowing in each voxel (% 
where S int is the b 0 intercept of the monoexponential fit of high bvalue data. Then, F p was calculated as:
These values of D and F p were then fixed, and D* was calculated using a partially constrained non-linear regression of all data sets according to Eq. [2] . In all subjects (healthy volunteers and CKD patients), the cortico-medullary difference of each DW parameter (DADC, DD, DD*, and DF p ) was defined in order to minimize interindividual variations. DW parameters were expressed as mean value in the ROIs 6 standard deviation.
Data Analysis
Phantom results allowed us to quantify the ADC variability between DW sequences in stable and reproducible conditions. ROIs were manually drawn within the two different compartments using OsiriX software (http://www.osirix-viewer.com/). ADC comparison between (i) ss-EPI and (j) RESOLVE sequences was done using the coefficient of variation CV [%] expressed as:
Comparison between ss-EPI and RESOLVE sequences was done in healthy volunteers, with a paired t-test between mean DDW parameters. An experienced uroradiologist (20 years) was consulted to ensure the quality of images for diagnostic purposes.
A fibrosis threshold of 40% was selected, as reported previously, 12 to separate all subjects (healthy volunteers and CKD patients) into two groups according to the level of fibrosis: one group (low to moderate fibrosis group) with a level of interstitial fibrosis lower than 40% (n 5 28) and the second group (high fibrosis group) with more than 40% (n 5 7). Welch's two-sample ttest was computed between groups for DWI parameters of ss-EPI and RESOLVE sequences. The limit of 40% of interstitial fibrosis was also used to stratify the area under the curves (AUC) of the receiver operating characteristics (ROC). ROC curves, plotting the true positive versus the false positive prediction rates, were used to assess the discrimination power of DADC of ss-EPI and RESOLVE sequences. ROC curves were considered "paired." Comparison between them was based on AUCs and done with the DeLong method, 17 available in the package pROC 18 of R software (v. 0.98.1091). The linear relationship between DWI parameters of both MR sequences and interstitial fibrosis was tested using the Pearson product-moment correlation coefficient. Linear correlations with P < 0.05 were considered as moderate at R 2 > 0.20 and strong at R 2 > 0.45. The significance of the difference between correlation coefficients was performed using the Fisher Z-transform. A P-value of less than 0.05 was considered to indicate a statistically significant difference.
Results
Phantom
Compared to images from the RESOLVE sequence, the ADC map from ss-EPI showed more susceptibility artifacts due to the air-filled compartment, as shown in Fig. 1 . However, no differences were found between ss-EPI and RESOLVE sequences for quantification of ADC when measured in the center of the phantom free of artifacts. Mean ADC values of each compartment are shown in Table 1 . A coefficient of variation (CV) less than 3% was measured between the two DW sequences.
Healthy Volunteers
A cortico-medullary contrast with a positive DADC, as shown in Fig. 2A , was measured with both DW sequences. In healthy volunteers, ss-EPI and RESOLVE sequences had no significant difference between DW parameters, as shown in Table 2 .
Interstitial Fibrosis Assessment
The level of interstitial fibrosis measured in CKD patients from Masson trichrome ranged from 0-80% with a mean interstitial fibrosis of 31 6 20%. An example of b 0 image and ADC, D, and D* maps obtained from ss-EPI and RESOLVE sequences in a CKD patient with 30% of interstitial fibrosis is shown in Fig. 2B . During assessment for diagnostic quality it was observed that, compared to healthy volunteers, a loss of cortico-medullary differentiation was visible on both DW sequences in all patients with a high level of interstitial fibrosis. For both DW sequences, DADC was significantly lower in the high fibrosis group compared to the low fibrosis group (P 5 0.003 for ss-EPI and P 5 3.1 3 10 -6 for RESOLVE). The RESOLVE sequence with DADC led to a specificity and sensitivity of 100% and 86%, and the ss-EPI led to a specificity of 82% and sensitivity of 86% but, no significant difference of AUCs was measured between ss-EPI and RESOLVE using the fibrosis threshold of 40%, as shown in Fig. 3 (P 5 0.16 between AUCs of ss-EPI and RESOLVE with the Delong method). DADC from both DW sequences was linearly correlated with the percentage of fibrosis, as shown in Fig. 4A . DADC from RESOLVE had a significantly better correlation with interstitial fibrosis than DADC obtained with ss-EPI (P 5 0.04, according to R 2 correlation comparison using the Fisher Z-transform).
Regarding the biexponential fitting parameters, a significant decrease of mean DD was measured in the high fibrosis group compared to the low fibrosis group for both sequences (P 5 0.02 for ss-EPI and P 5 8. 
Discussion
The main result of this study is that the RESOLVE sequence derived DADC (ADC cortico-medullary difference) was superior to ss-EPI-derived DADC, as shown by a stronger linear correlation with the percentage of fibrosis from biopsy.
In the present study, we extended previous comparison of RESOLVE and ss-EPI sequences that were based only on image quality analysis 10 by including a comparison of DW parameters in a phantom and CKD patients. In the center of the gel phantom in a region free of susceptibility artifacts, no ADC difference was measured between ss-EPI and RESOLVE sequences, attesting the absence of systematic bias between both sequences. Several studies had previously found an improvement of the global DW image quality with the RESOLVE strategy due mainly to reduced T Ã 2 blurring and susceptibility 
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No significant difference in all DW parameters was seen between ss-EPI and RESOLVE sequences. P > 0.05 for all parameters/markers.
effects, mainly resulting in an enhancement of tumor lesion detection in various organs, such as head and neck region, 19, 20 breast, [21] [22] [23] pelvis, 24 thyroid, 25 and rectum. 26 All these studies showed that the greater tumor lesion to normal tissue contrast from RESOLVE resulted in a better ADC differentiation of healthy tissues and tumors. Except in one study of the parotid glands, 20 which showed no significant difference in tumoral ADC values between RESOLVE and ss-EPI, a significantly lower ADC value was always measured with the readoutsegmented strategy within malignant lesions in all these other studies. In our study, a larger negative DADC was measured with RESOLVE by comparison to ss-EPI in patients with more than 40% of interstitial fibrosis. The explanation of this ADC difference between RESOLVE and ss-EPI measured in pathologies, but not seen in healthy tissues, is still unclear and under debate. The better delineation of lesions by the RESOLVE sequence [21] [22] [23] [27] [28] [29] [30] could decrease the averaging with adjacent high ADC values of normal tissues and, thus, preserve the lower ADC values in the tumor as observed in breast cancer. 22 However, Zhao et al 31 contested that adjacent FIGURE 4: Correlations between DADC (A), DD (B), DD* (C), DF p (D) and renal interstitial fibrosis from ss-EPI and RESOLVE sequences. Data were acquired from 35 subjects (27 CKD patients and eight healthy volunteers). DADC from RESOLVE was better correlated to renal interstitial fibrosis than DADC from ss-EPI (P 5 0.04 by R 2 correlation comparison using the Fisher Z-transform). Regarding biexponential fitting parameters, correlations between DD and renal interstitial fibrosis were observed for the RESOLVE sequence only. DADC from ss-EPI and DD from RESOLVE gave equivalent correlation with the percentage of fibrosis. All other correlations were not significant, suggesting that the intravoxel incoherent motion parameters of perfusion (DD*) and fraction of perfusion (DF p ) were not linked to renal interstitial fibrosis in our population. FIGURE 3: AUC of the ROC using 40% of interstitial fibrosis as a limit for renal fibrosis detection by DADC. All patients with more than 40% of interstitial fibrosis had a negative DADC, whereas all patients with less than 40% had a positive DADC, resulting in an AUC from the RESOLVE sequence obtained with 10 b-values equal to 1. A weaker ability to separate a high level and low level of fibrosis was measured with the ss-EPI sequence with a reduced AUC, attesting the presence of true positive and/or false positive. However, no significant difference of AUCs was measured between ss-EPI and RESOLVE using the fibrosis threshold of 40%.
Friedli et al.: RESOLVE and ss-EPI to Assess Renal Fibrosis
high ADC values of normal tissues could impact the ADC values measured in the lesion. They compared in terms of ADC values, RESOLVE, and ss-EPI in the brainstem and sinonasal lesions. The sinonasal lesions, which were not surrounded by high ADC values of normal tissues, had significantly lower ADC values on RESOLVE compared to ss-EPI. By contrast, the brainstem measurements, less affected by the susceptibility artifacts and ghosts than sinonasal lesions, exhibited no significant differences between the two DW sequences. They concluded that the difference in ADC values could be more attributed to susceptibility artifacts and ghosts, present in the sinonasal lesions DW images, than by adjacent high ADC values of normal tissues. In our case, both effects (ie, a reduction of susceptibility effects preserving the cortex from artifacts and an improved anatomical delineation) could explain the better performance of the RESOLVE sequence.
The biexponential-fitting values measured in the current study had comparable values with those reported in previous studies on kidney allograft patients, 32 ,33 but did not allow us to discriminate the level of interstitial fibrosis. The biexponential-fitting parameters with either the ss-EPI or RESOLVE sequence were not significantly correlated with the percentage of fibrosis from biopsy. We therefore concluded that the biexponential model is inadequate to robustly assess the percentage of kidney fibrosis in our population. This result was consistent with another study, which found an absence of correlation in diffuse liver fibrosis. 34 In addition, biexponential parameters in the kidney have been shown not to correlate significantly with enhanced glomerular filtration rate (eGFR), 35, 36 which is in turn correlated with renal interstitial fibrosis. 12 The major difficulties of using a biexponential fitting are the large variability in the resulting parameters and the lack of robustness against noise. 37 Also, despite the use of physiological triggering schemes to limit respiratory artifacts, physiological motion artifacts that lead to inhomogeneous signal dropout can impact kidney images. We might expect that biexponential fitting would be more sensitive to decreases of signal intensity, as more points are needed to build the fit. An increase of D* has been measured with the increase of eGFR. 33 However, the correlation was relatively weak, probably due to the large variability of D* due to the fitting. [38] [39] [40] An interpatient coefficient of variation (CV) of 25% was found for the F p parameter in a study on the variability of biexponential parameters in renal allograft patient after transplantation (5-19 days). 41 Despite the use of the cortico-medullary difference and the RESOLVE sequence, which reduced intersubject variability compared to the cortical or medullary ADC, we found that biexponential parameters with DD, DD*, and DF p did not accurately assess renal fibrosis. The relevance of the biexponential model in general is still subject to debate. There are some inherent limitations of our study. The size of our population was restricted, especially in terms of patients with a high level of fibrosis (>40%), as few patients with acute kidney disease or CKD and a high level of fibrosis had routine biopsy. Fibrosis in healthy volunteers was not measured, but these subjects were considered to have no fibrosis. This could introduce an additional error; however, such an assumption is valid in a relatively young population, all under 30 years of age, thus avoiding age-related fibrosis. The lack of perfusion in the diffusion phantom limits its use to ADC calculation in stable and reproducible condition and does not allow biexponential fitting parameters assessment. An implementation of Lemke's correction 39 by acquiring T 1 and T 2 maps would be appropriate to take into account T 2 effects and correct the F p parameter for the biexponential. However, in case of chronic disease, we would not expect a significant difference in T 2 values between subjects, and therefore the uncorrected F p , while not the true value, could be compared between the DW sequences. Finally, this study supports the advantages of DADC from the RESOLVE sequence to assess renal interstitial fibrosis, despite the longer acquisition time compared to the conventional ss-EPI. An alternative approach would be to acquire the ss-EPI sequence with more averages on b-values such that the scan time would have been equivalent to RESOLVE. This strategy could be used to increase the signal-to-noise ratio and therefore improve ss-EPI analysis. However, this would not correct for off-resonance effects maintaining this disadvantage over RESOLVE. The initial goal of this study was to verify if there is a benefit of using the RESOLVE strategy compared to the inherently shorter acquisition time ss-EPI. It would be worthwhile in future work to verify if reducing the number of b-values could shorten the acquisition time without impacting DWI parameters. Such an analysis is beyond the scope of the current study aiming to compare ss-EPI and RESOLVE with DW parameters obtained with monoexponential and biexponential fitting for interstitial fibrosis assessment.
In conclusion, DADC derived from both RESOLVE and ss-EPI is sensitive to fibrosis. DADC from RESOLVE has a significantly better correlation with interstitial fibrosis than DADC from ss-EPI. Biexponential-fitting parameters showed no advantage for renal interstitial fibrosis assessment for either sequence. Despite a longer acquisition time compared to ss-EPI, the use of the RESOLVE sequence with DADC calculation to assess renal interstitial fibrosis is therefore recommended.
